Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis

Antioxidants and Redox Signaling

Volumn 19, Issue 7, 2013, Pages 644-660

  Skrzypek, Klaudia ^a,b   Tertil, Magdalena ^a,b   Golda, Slawomir ^a   Ciesla, MacIej ^a   Weglarczyk, Kazimierz ^b,c   Collet, Guillaume ^b   Guichard, Alan ^b   Kozakowska, Magdalena ^a   Boczkowski, Jorge ^d   Was, Halina ^a   Gil, Tomasz ^e   Kuzdzal, Jaroslaw ^e   Muchova, Lucie ^f   Vitek, Libor ^f   Loboda, Agnieszka ^a   Jozkowicz, Alicja ^a   Kieda, Claudine ^b   Dulak, Jozef ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b CENTRE DE BIOPHYSIQUE MOLÉCULAIRE   (France)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^d INSERM U955   (France)

^e JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^f CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; CARBON MONOXIDE; DOXORUBICIN; FLUOROURACIL; HEME OXYGENASE 1; INTERLEUKIN 7; MICRORNA; MICRORNA 378; MUCIN 5AC; PROTEIN P53; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; CANCER GROWTH; CANCER INHIBITION; CANCER RESISTANCE; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DISTANT METASTASIS; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG ADENOCARCINOMA; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; REVIEW; TUMOR VASCULARIZATION; UPREGULATION;

EID: 84881410991     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5184     Document Type: Review

References (57)

1. Acunzo M, Visone R, Romano G, Veronese A, Lovat F, Palmieri D, Bottoni A, Garofalo M, Gasparini P, Condorelli G, Chiariello M, and Croce CM. miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222. Oncogene 31: 634-642, 2012.
2. Alexiou P, Vergoulis T, Gleditzsch M, Prekas G, Dalamagas T, Megraw M, Grosse I, Sellis T, and Hatzigeorgiou AG. miRGen 2.0: a database of microRNA genomic information and regulation. Nucleic Acids Res 38: D137-D141, 2010.
3. Chamorro-Jorganes A, Araldi E, Penalva LO, Sandhu D, Fernandez-Hernando C, and Suarez Y. MicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1. Arterioscler Thromb Vasc Biol 31: 2595-2606, 2011.
4. Chen LT, Xu SD, Xu H, Zhang JF, Ning JF, and Wang SF. MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis. Med Oncol 29: 1673-1680, 2012.
5. De Palma G, Mozzoni P, Acampa O, Internullo E, Carbognani P, Rusca M, Goldoni M, Corradi M, Tiseo M, Apostoli P, and Mutti A. Expression levels of some antioxidant and epidermal growth factor receptor genes in patients with early-stage non-small cell lung cancer. J Nucleic Acids 2010: 147528, 2010.
6. Deininger MH, Meyermann R, Trautmann K, Duffner F, Grote EH, Wickboldt J, and Schluesener HJ. Heme oxygenase (HO)-1 expressing macrophages/microglial cells accumulate during oligodendroglioma progression. Brain Res 882: 1-8, 2000.
7. Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT, and Thomas-Tikhonenko A. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 38: 1060-1065, 2006. (Pubitemid 44325933)
8. Eichner LJ, Perry MC, Dufour CR, Bertos N, Park M, St-Pierre J, and Giguere V. miR-378(*) mediates metabolic shift in breast cancer cells via the PGC-1beta/ERRgamma transcriptional pathway. Cell Metab 12: 352-361, 2010.
9. Feng M, Li Z, Aau M, Wong CH, Yang X, and Yu Q. Myc/ miR-378/TOB2/cyclin D1 functional module regulates oncogenic transformation. Oncogene 30: 2242-2251, 2011.
10. Ferrando M, Gueron G, Elguero B, Giudice J, Salles A, Leskow FC, Jares-Erijman EA, Colombo L, Meiss R, Navone N, De Siervi A, and Vazquez E. Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer. Angiogenesis 14: 467-479, 2011.
11. Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, and Shu Y. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed Pharmacother 64: 399-408, 2010.
12. Grochot-Przeczek A, Lach R, Mis J, Skrzypek K, Gozdecka M, Sroczynska P, Dubiel M, Rutkowski A, Kozakowska M, Zagorska A, Walczynski J, Was H, Kotlinowski J, Drukala J, Kurowski K, Kieda C, Herault Y, Dulak J, and Jozkowicz A. Heme oxygenase-1 accelerates cutaneous wound healing in mice. PLoS One 4: -e5803, 2009.
13. Gueron G, De Siervi A, Ferrando M, Salierno M, De Luca P, Elguero B, Meiss R, Navone N, and Vazquez ES. Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells. Mol Cancer Res 7: 1745-1755, 2009.
14. Hill M, Pereira V, Chauveau C, Zagani R, Remy S, Tesson L, Mazal D, Ubillos L, Brion R, Asghar K, Mashreghi MF, Kotsch K, Moffett J, Doebis C, Seifert M, Boczkowski J, Osinaga E, and Anegon I. Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3-dioxygenase. FASEB J 19: 1957-1968, 2005. (Pubitemid 41759741)
15. Hofmann HS, Hansen G, Richter G, Taege C, Simm A, Silber RE, and Burdach S. Matrix metalloproteinase-12 expression correlates with local recurrence and metastatic disease in non-small cell lung cancer patients. Clin Cancer Res 11: 1086-1092, 2005. (Pubitemid 40175757)
16. Hua Z, Lv Q, Ye W, Wong CK, Cai G, Gu D, Ji Y, Zhao C, Wang J, Yang BB, and Zhang Y. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 1: -e116, 2006.
17. Jevnaker AM, Khuu C, Kjole E, Bryne M, and Osmundsen H. Expression of members of the miRNA17-92 cluster during development and in carcinogenesis. J Cell Physiol 226: 2257-2266, 2011.
18. Jozkowicz A, Was H, and Dulak J. Heme oxygenase-1 in tumors: is it a false friend? Antioxid Redox Signal 9: 2099-2117, 2007. (Pubitemid 350059009)
19. Kikuchi A, Yamaya M, Suzuki S, Yasuda H, Kubo H, Nakayama K, Handa M, Sasaki T, Shibahara S, Sekizawa K, and Sasaki H. Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism. Hum Genet 116: 354-360, 2005. (Pubitemid 40521111)
20. Kozakowska M, Ciesla M, Stefanska A, Skrzypek K, Was H, Jazwa A, Grochot-Przeczek A, Kotlinowski J, Szymula A, Bartelik A, Mazan M, Yagensky O, Florczyk U, Lemke K, Zebzda A, Dyduch G, Nowak W, Szade K, Stepniewski J, Majka M, Derlacz R, Loboda A, Dulak J, and Jozkowicz A. Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs. Antioxid Redox Signal 16: 113-127, 2012.
21. Labelle M, Begum S, and Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 20: 576-590, 2011.
22. Lago CU, Sung HJ, Ma W, Wang PY, and Hwang PM. p53, aerobic metabolism, and cancer. Antioxid Redox Signal 15: 1739-1748, 2011.
23. Landi MT, Zhao Y, Rotunno M, Koshiol J, Liu H, Bergen AW, Rubagotti M, Goldstein AM, Linnoila I, Marincola FM, Tucker MA, Bertazzi PA, Pesatori AC, Caporaso NE, McShane LM, and Wang E. MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res 16: 430-441, 2010.
24. Lee DY, Deng Z, Wang CH, and Yang BB. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci U S A 104: 20350-20355, 2007.
25. Lee J, Lee SK, Lee BU, Lee HJ, Cho NP, Yoon JH, Choi HR, and Kim EC. Upregulation of heme oxygenase-1 in oral epithelial dysplasias. Int J Oral Maxillofac Surg 37: 287-292, 2008. (Pubitemid 351335238)
26. Lee PJ, Alam J, Wiegand GW, and Choi AM. Overexpression of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. Proc Natl Acad Sci U S A 93: 10393-10398, 1996. (Pubitemid 26314633)
27. Lei Z, Li B, Yang Z, Fang H, Zhang GM, Feng ZH, and Huang B. Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. PLoS One 4: -e7629, 2009.
28. Li J, Liang S, Yu H, Zhang J, Ma D, and Lu X. An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer. Gynecol Oncol 119: 543-548, 2010.
29. Li XF, Yan PJ, and Shao ZM. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer. Oncogene 28: 3937-3948, 2009.
30. Liu F, Lou YL, Wu J, Ruan QF, Xie A, Guo F, Cui SP, Deng ZF, and Wang Y. Upregulation of MicroRNA-210 Regulates Renal Angiogenesis Mediated by Activation of VEGF Signaling Pathway under Ischemia/Perfusion Injury in vivo and in vitro. Kidney Blood Press Res 35: 182-191, 2011.
31. Liu S, Guo W, Shi J, Li N, Yu X, Xue J, Fu X, Chu K, Lu C, Zhao J, Xie D, Wu M, and Cheng S. MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. J Hepatol 56: 389-396, 2012.
32. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, and Golub TR. MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005. (Pubitemid 40839735)
33. Maines MD, Trakshel GM, and Kutty RK. Characterization of two constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible. J Biol Chem 261: 411-419, 1986. (Pubitemid 16103962)
34. Marinissen MJ, Tanos T, Bolos M, de Sagarra MR, Coso OA, and Cuadrado A. Inhibition of heme oxygenase-1 interferes with the transforming activity of the Kaposi sarcoma herpesvirus-encoded G protein-coupled receptor. J Biol Chem 281: 11332-11346, 2006. (Pubitemid 43855558)
35. Matsuyama H, Suzuki HI, Nishimori H, Noguchi M, Yao T, Komatsu N, Mano H, Sugimoto K, and Miyazono K. miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma. Blood 118: 6881-6892, 2011.
36. McAllister SC, Hansen SG, Ruhl RA, Raggo CM, DeFilippis VR, Greenspan D, Fruh K, and Moses AV. Kaposi sarcomaassociated herpesvirus (KSHV) induces heme oxygenase-1 expression and activity in KSHV-infected endothelial cells. Blood 103: 3465-3473, 2004. (Pubitemid 38525679)
37. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, Lim B, and Rigoutsos I. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126: 1203-1217, 2006. (Pubitemid 44380294)
38. Mishra PJ, Song B, Wang Y, Humeniuk R, Banerjee D, Merlino G, Ju J, and Bertino Jr. MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism. PLoS One 4: -e8445, 2009.
39. Mohri T, Nakajima M, Fukami T, Takamiya M, Aoki Y, and Yokoi T. Human CYP2E1 is regulated by miR-378. Biochem Pharmacol 79: 1045-1052, 2010.
40. Nowis D, Legat M, Grzela T, Niderla J, Wilczek E, Wilczynski GM, Glodkowska E, Mrowka P, Issat T, Dulak J, Jozkowicz A, Was H, Adamek M, Wrzosek A, Nazarewski S, Makowski M, Stoklosa T, Jakobisiak M, and Golab J. Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity. Oncogene 25: 3365-3374, 2006. (Pubitemid 43880305)
41. Rothe F, Ignatiadis M, Chaboteaux C, Haibe-Kains B, Kheddoumi N, Majjaj S, Badran B, Fayyad-Kazan H, Desmedt C, Harris AL, Piccart M, and Sotiriou C. Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer. PLoS One 6: -e20980, 2011.
42. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, and Quackenbush J. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34: 374-378, 2003. (Pubitemid 36184095)
43. Sarkar S, Dey BK, and Dutta A. MiR-322/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A. Mol Biol Cell 21: 2138-2149, 2010.
44. Sunamura M, Duda DG, Ghattas MH, Lozonschi L, Motoi F, Yamauchi J, Matsuno S, Shibahara S, and Abraham NG. Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis 6: 15-24, 2003. (Pubitemid 37305335)
45. Taha H, Skrzypek K, Guevara I, Nigisch A, Mustafa S, Grochot-Przeczek A, Ferdek P, Was H, Kotlinowski J, Kozakowska M, Balcerczyk A, Muchova L, Vitek L, Weigel G, Dulak J, and Jozkowicz A. Role of heme oxygenase-1 in human endothelial cells: lesson from the promoter allelic variants. Arterioscler Thromb Vasc Biol 30: 1634-1641, 2010.
46. Takahashi S, Takahashi T, Mizobuchi S, Matsumi M, Yokoyama M, Morita K, Miyazaki M, Namba M, Akagi R, and Sassa S. CYP2E1 overexpression up-regulates both nonspecific delta-aminolevulinate synthase and heme oxygenase-1 in the human hepatoma cell line HLE/2E1. Int J Mol Med 11: 57-62, 2003.
47. Torisu-Itakura H, Furue M, Kuwano M, and Ono M. Co-expression of thymidine phosphorylase and heme oxygenase-1 in macrophages in human malignant vertical growth melanomas. Jpn J Cancer Res 91: 906-910, 2000.
48. Tsai KW, Wu CW, Hu LY, Li SC, Liao YL, Lai CH, Kao HW, Fang WL, Huang KH, Chan WC, and Lin WC. Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. Int J Cancer 129: 2600-2610, 2011.
49. Tsuji MH, Yanagawa T, Iwasa S, Tabuchi K, Onizawa K, Bannai S, Toyooka H, and Yoshida H. Heme oxygenase-1 expression in oral squamous cell carcinoma as involved in lymph node metastasis. Cancer Lett 138: 53-59, 1999. (Pubitemid 29189184)
50. Vasudevan S, Tong Y, and Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science 318: 1931-1934, 2007.
51. Wang S and Olson EN. AngiomiRs -key regulators of angiogenesis. Curr Opin Genet Dev 19: 205-211, 2009.
52. Was H, Cichon T, Smolarczyk R, Rudnicka D, Stopa M, Chevalier C, Leger JJ, Lackowska B, Grochot A, Bojkowska K, Ratajska A, Kieda C, Szala S, Dulak J, and Jozkowicz A. Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice. Am J Pathol 169: 2181-2198, 2006. (Pubitemid 351181977)
53. Was H, Dulak J, and Jozkowicz A. Heme oxygenase-1 in tumor biology and therapy. Curr Drug Targets 11: 1551-1570, 2010.
54. Was H, Sokolowska M, Sierpniowska A, Dominik P, Skrzypek K, Lackowska B, Pratnicki A, Grochot-Przeczek A, Taha H, Kotlinowski J, Kozakowska M, Mazan A, Nowak W, Muchova L, Vitek L, Ratajska A, Dulak J, and Jozkowicz A. Effects of heme oxygenase-1 on induction and development of chemically induced squamous cell carcinoma in mice. Free Radic Biol Med 51: 1717-1726, 2011.
55. Yanagawa T, Omura K, Harada H, Nakaso K, Iwasa S, Koyama Y, Onizawa K, Yusa H, and Yoshida H. Heme oxygenase-1 expression predicts cervical lymph node metastasis of tongue squamous cell carcinomas. Oral Oncol 40: 21-27, 2004. (Pubitemid 37510208)
56. Yu CJ, Yang PC, Shun CT, Lee YC, Kuo SH, and Luh KT. Overexpression of MUC5 genes is associated with early post-operative metastasis in non-small-cell lung cancer. Int J Cancer 69: 457-465, 1996.
57. Zhang Y, Liao JM, Zeng SX, and Lu H. p53 downregulates Down syndrome-associated DYRK1A through miR-1246. EMBO Rep 12: 811-817, 2011.